Neuropathic Pain

Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system. It is distinguished from nociceptive pain by its mechanism, its characteristic symptoms such as burning, shooting, or electric-shock sensations, and accompanying sensory signs, and it requires a grading approach to establish how confidently it can be attributed to a nervous-system lesion.

Definition

Neuropathic pain is pain arising as a direct consequence of a lesion or disease affecting the somatosensory nervous system, classified by a graded scheme into possible, probable, and definite categories based on history, sensory signs, and confirmatory testing.

Scope

This topic covers the IASP definition and grading of neuropathic pain, its peripheral and central subtypes, its mechanisms, and the structure of its evidence base. It is reference material on classification and mechanism and does not provide individualized diagnostic or prescribing guidance.

Core questions

• What distinguishes neuropathic pain from nociceptive and nociplastic pain?
• How does the graded definition (possible, probable, definite) establish the level of certainty?
• What are the principal peripheral and central causes of neuropathic pain?
• How is the evidence for pharmacological management of neuropathic pain structured?

Key concepts

• Lesion or disease of the somatosensory system
• Peripheral versus central neuropathic pain
• Grading: possible, probable, definite
• Allodynia and hyperalgesia
• Central sensitization
• Negative and positive sensory signs
• Chronic neuropathic pain (ICD-11 MG30.5)

Mechanisms

Neuropathic pain follows damage to peripheral nerves, roots, the spinal cord, or the brain's somatosensory pathways. Such injury alters neuronal excitability and connectivity, producing ectopic firing, reduced inhibition, and central sensitization, the amplification of nociceptive signalling within the central nervous system (Woolf, 2011). The graded definition requires that pain be in a neuroanatomically plausible distribution and that a relevant lesion be demonstrable to move from possible to probable and definite neuropathic pain (Treede et al., 2008; Finnerup et al., 2016). The ICD-11 classification separates peripheral from central chronic neuropathic pain (Scholz et al., 2019).

Clinical relevance

Recognizing the neuropathic mechanism shapes how clinicians interpret a pain complaint and appraise treatment evidence, because neuropathic pain responds to a different evidence base than nociceptive pain. This entry describes that classification and mechanism as reference knowledge; it does not direct individual diagnosis or treatment.

Epidemiology

Population estimates suggest neuropathic pain affects a notable proportion of adults, with common causes including painful diabetic polyneuropathy, postherpetic neuralgia, trigeminal neuralgia, post-stroke pain, and nerve injury. Central neuropathic pain accompanies conditions such as spinal cord injury and multiple sclerosis.

Evidence & guidelines

The IASP graded definition and its ICD-11 implementation provide the framework for classifying neuropathic pain (Treede et al., 2008; Finnerup et al., 2016; Scholz et al., 2019). A systematic review and meta-analysis by the NeuPSIG group summarized the evidence for pharmacotherapy and informed recommendations on first-line agents (Finnerup et al., 2015).

History

The concept of neuropathic pain was sharpened in 2008 when an IASP special-interest group proposed a redefinition tied to a demonstrable lesion of the somatosensory system and a grading system to express diagnostic certainty (Treede et al., 2008). This grading was updated in 2016 (Finnerup et al., 2016) and incorporated into the ICD-11 chronic pain classification (Scholz et al., 2019), consolidating neuropathic pain as a distinct mechanistic category.

Debates

How certain can a neuropathic pain diagnosis be without confirmatory testing?

The graded scheme reserves 'definite' neuropathic pain for cases with confirmatory evidence of a lesion, leaving many clinical presentations at the 'possible' or 'probable' level, which shapes how confidently the label is applied.

Key figures

• Rolf-Detlef Treede
• Nanna B. Finnerup
• Troels S. Jensen
• Joachim Scholz
• Clifford J. Woolf

Seminal works

• treede-2008
• finnerup-2016
• scholz-2019

Frequently asked questions

How is neuropathic pain different from ordinary musculoskeletal pain?

Neuropathic pain results from damage or disease of the nervous system itself, rather than from tissue injury, and it typically produces burning, shooting, or electric-shock sensations along with sensory changes in the affected area.

What do 'possible', 'probable', and 'definite' neuropathic pain mean?

They are levels of a grading system: 'possible' rests on history and distribution, 'probable' adds confirmatory sensory signs, and 'definite' requires objective evidence of a relevant nervous-system lesion.